Orphan Drug Approval Takeaways From Recent FDA Data
Several members of Congress have touted the Fairness in Orphan Drug Exclusivity Act, passed by the U.S. House of Representatives in May,[1] as a bill that closes a loophole in the...To view the full article, register now.
Already a subscriber? Click here to view full article